BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28169837)

  • 1. Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients With Indeterminate Extrahepatic Disease on 18FDG-PET Scan Before Liver Resection for Metastatic Colorectal Cancer.
    Wong GYM; Kumar R; Beeke C; Ullah S; Chen J; Karapetis C; Price T; Padbury R
    Ann Surg; 2018 May; 267(5):929-935. PubMed ID: 28169837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
    Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M
    Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
    Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D
    Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 18FDG PET/CT in the management of colorectal liver metastases.
    Engledow AH; Skipworth JR; Pakzad F; Imber C; Ell PJ; Groves AM
    HPB (Oxford); 2012 Jan; 14(1):20-5. PubMed ID: 22151447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
    Serrano PE; Gu CS; Moulton CA; Gallinger S
    Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis.
    Pulitanò C; Bodingbauer M; Aldrighetti L; de Jong MC; Castillo F; Schulick RD; Parks RW; Choti MA; Wigmore SJ; Gruenberger T; Pawlik TM
    Ann Surg Oncol; 2011 May; 18(5):1380-8. PubMed ID: 21136180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease.
    Carpizo DR; D'Angelica M
    Ann Surg Oncol; 2009 Sep; 16(9):2411-21. PubMed ID: 19554376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery?
    Adam R; de Haas RJ; Wicherts DA; Vibert E; Salloum C; Azoulay D; Castaing D
    Ann Surg; 2011 Feb; 253(2):349-59. PubMed ID: 21178761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET-CT is effective in selecting patients with poor long term survivals for colorectal liver metastases.
    Yip VS; Poston GJ; Fenwick SW; Wieshmann H; Athwal T; Malik HZ
    Eur J Surg Oncol; 2014 Aug; 40(8):995-9. PubMed ID: 24290370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
    Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
    Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
    Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
    Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of FDG-PET in the selection of patients with colorectal liver metastases.
    Wiering B; Krabbe PF; Dekker HM; Oyen WJ; Ruers TJ
    Ann Surg Oncol; 2007 Feb; 14(2):771-9. PubMed ID: 17086488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
    Fernandez FG; Drebin JA; Linehan DC; Dehdashti F; Siegel BA; Strasberg SM
    Ann Surg; 2004 Sep; 240(3):438-47; discussion 447-50. PubMed ID: 15319715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation?
    Diaconescu A; Alexandrescu S; Ionel Z; Zlate C; Grigorie R; Brasoveanu V; Hrehoret D; Ciurea S; Botea F; Tomescu D; Droc G; Croitoru A; Herlea V; Boros M; Grasu M; Dumitru R; Toma M; Ionescu M; Vasilescu C; Popescu I
    Chirurgia (Bucur); 2017; 112(6):673-682. PubMed ID: 29288609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
    Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
    J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
    Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
    Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
    Metser U; Halankar J; Langer D; Mohan R; Hussey D; Hadas M; Tamir S
    Ann Nucl Med; 2017 Feb; 31(2):153-162. PubMed ID: 27848159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.